Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Iām not here to call this stock, Mr truth, Iām here to share my research and have fun waiting for the inevitable FDA approval decision. Traders can do anything they like, to try predict their next gambling fix for all I care.
Sorry wyn the price doesnāt drop from 160 odd to 80 based on a chart when they were presenting to the institutional investors about a placing. It was leaked and sold into. No graph is going to compensate for news like that.
It wasnāt charting that caused the drop it was people in the know. Also on other news I wonder if the presentation Dr Smith has on the 30th has some 2w data available thatās been running for a while now they will have a good idea whatās go on already, especially considering lower more frequent doses seems to be the sweet spot anyways.
Donāt know why anyone would bother charting an aim company tbh. News could arrive at anytime especially considering Avacta research obsessed PI base that can uncover and share things 3-4 days before an RNS arrives (for example launch in Germany is that not RNS worthy?)
Windy on FDA approval in your opinion on the assumption of what oncology drugs are usually valued at not to mention FDA validation of the platform, do we surpass our all time high of 285p? If the answer is yes which letās be honest itās hard to argue against that, no matter what you bought in for you will still be making a profitā¦ some people will be making more profits than others however worst case even if you bought at our ATH you would still be making a profit on FDA approval of AVA6000. Hence why I said if you believe in FDA approval you will make money.
All that matters is how much Avacta is worth on FDA approval of AVA6000. Everything else in the meantime is irrelevant, if you believe FDA approval will happen. Main macro points are we are funded and the data is exceptional. All you need to do now is wait for the trials to conclude, which they will in due course and wait for the FDAās decision. Talking about the past or management etc will have no impact on the trial results and whether the FDA will give the green light.
Hopefully the 2w results will be released by then so we donāt have to listen to the folk that are venting about our management team constantly or they have lost confidence in their investment š¤®š¤®. (without all the information) instead of emailing the company. No wonder sentiment is shot reading some posts here you would think the company is a guaranteed failure. Interesting to note is Amazon was pretty much in the same boat. Share price completely decimated sentiment all time low. However the CEO could see the internal metrics and because they didnāt need the share price up to raise cash off the equity markets just ignored it and got on with the day job. Look how that turned out.
Not particularly as not interested and like many others I am holding a significant loss, not hidden that, however itās being diluted very effectively at these levels. Hindsight is wonderful I think we can all agree we would have preferred to sell out at 160p and buy back in at 45p however thatās not my style, I do the research and happy to wait for the catalyst of FDA approval then see what happens. If the FDA approves this I am still a massive winner without taking any chances. Imagine selling 160 then a LD hit and it surged to 400 ouch you donāt win all the time.
I prefer to keep my average private, however I can assure you I own many shares here and firmly believe the technology will come good and we will get FDA approval in due course. This is a sale for me. Nothing has materially changed since Nov, apart from outrage against the management team. That is a storm in a tea cup.
Jesus the desperation on the BB is unbelievable, just because we raised at 50p, was everyone moaning about Dr Smith when we were down at 38p in 2022 then rapidly rose back up to 185 odd, people have short memories. The way people are talking you would have thought the trial has completely failed and we have all lost our cash š¤¦āāļø. As for you Thorn go watch the presentation educate yourself, and as for my average price I have been topping up accumulating at these low levels didnāt think I would ever get the opportunity tbh. Why wouldnāt you institutional investors were oversubscribed at 50p for 26 million odd at a so called 34% discount. Everyone needs to ask themselves, what has really changed since Nov when we were 160p is it anything material (trial failures), or is folk just got faux outrage at the management team because they decided to raise at a shock discount and sentiment has been eroded temporarily. The same people giving up hope now calling for change will likely be shouting Avacta praises once the data released for the 2w study mid year. AVA6000 works dox will do what dox does on tumours sensitive to it. People really need to chill or write a letter to the management team. This will recover in time like it did the last time. Have some patience, we are getting to the efficacy studies now which are designed for success. If you are really wanting out go read up on why you invested in the first place then go watch the latest Q&As again and have some bottle. But donāt cry hereā¦..